We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 20, 2020

Pre- and Postoperative Capecitabine ± Oxaliplatin in Locally Advanced Rectal Cancer

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD
J. Clin. Oncol 2020 Oct 01;[EPub Ahead of Print], HJ Schmoll, A Stein, E Van Cutsem, T Price, RD Hofheinz, B Nordlinger, JF Daisne, J Janssens, B Brenner, H Reinel, S Hollerbach, K Caca, F Fauth, CV Hannig, J Zalcberg, N Tebbutt, ME Mauer, S Marreaud, MP Lutz, K Haustermans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading